Bahar U. Ulu

Are mesenchymal stem cells still effective in acute GvHD management?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 25, 2024

Is there a relationship between vitamin D levels and graft versus host disease?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 22, 2024

What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 22, 2024

What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 19, 2024

Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.

Journal: Bone marrow transplantation

Published: December 03, 2024

Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and Safety.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: August 28, 2024

Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilization.

Journal: Hematology, transfusion and cell therapy

Published: April 27, 2024

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey.

Journal: Annals of hematology

Published: July 28, 2022

Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience.

Journal: European review for medical and pharmacological sciences

Published: June 01, 2022

Are mesenchymal stem cells still effective in acute GvHD management?

Are mesenchymal stem cells still effective in acute GvHD management?

Is there a relationship between vitamin D levels and graft versus host disease?

Is there a relationship between vitamin D levels and graft versus host disease?

What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?

What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?

What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.

Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.

Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and Safety.

Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and Safety.

Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilization.

Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilization.

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey.

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey.

Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience.

Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience.

Nivolumab as a bridge to allogeneic hematopoietic stem cell transplantation is associated with improved survival.

Nivolumab as a bridge to allogeneic hematopoietic stem cell transplantation is associated with improved survival.

Pregnancy outcomes in female cancer survivors after hematopoietic stem cell transplantation.

Pregnancy outcomes in female cancer survivors after hematopoietic stem cell transplantation.

Could blood groups have prognostic significance on survival in patients with diffuse large B cell lymphoma?

Could blood groups have prognostic significance on survival in patients with diffuse large B cell lymphoma?